The CDC said nothing during this propaganda campaign.
FDA Citizen Petition/Anthrax Vaccine
I would like to ask that you please take a short minute or two to submit a comment to the FDA in support of the FDA citizen petition.
This petition is a valid and legal instrument that has been filed with FDA. It seeks action by the FDA commissioner concerning the anthrax vaccine. By law, FDA is required to respond to this petition.
All that you need to do is write something on the order of "I support this petition, docket number 01P-0471" Of course, more detailed comments are welcome.
Below is a summary of the petition. To read the Citizen Petition in full please go to Anthrax Vaccine Risks (the petition is above the web site counter)
Here you will also be able to read official documents of the General Accounting Office (GAO) Reports (the latest 10/01: Changes to the Manufacturing Process), FDA Reports and Congressional Testimony.
*When corresponding to the FDA please use the address below and insert in the subject area the following:
Address: fdadockets@oc.fda.gov
Subject: RE: Docket No. 01P-0471
Thank you for your time and concerns regarding the anthrax vaccine.
Sincerely, Jane
* * * * * * *
Dockets Management Branch
Department of Health and Human Services
Food and Drug Administration; Room 1-23
12420 Parklawn Drive
Rockville, Maryland 20857
CITIZEN PETITION:
The undersigned submit this petition under Section 360bbb-2 of the Federal Food, Drug and Cosmetic Act, section 553(e) of the Administrative Procedures Act, and Title 21 Subsection 10.30 of the Code of Federal Regulations to request the Commissioner of Food and Drugs to take the administrative actions listed below regarding anthrax vaccine adsorbed.
A. Action requested
(1) Issue a Final Rule on the drug category placement of anthrax vaccine as Category II (unsafe, ineffective, or misbranded) amending the as yet to be finalized Proposed Rule as published in the Federal Register 13 December 1985.
(2) Declare as adulterated all stockpiles of anthrax vaccine adsorbed in the possession of BioPort Corporation and all doses in private, public, U.S. or foreign government possession.
(3) Enforce FDA Compliance Policy Guide, Section 400.200 Consistent Application of CGMP Determinations (CPG 7132.12) with respect to anthrax vaccine adsorbed (license #1260).
(4) Revoke the anthrax vaccine adsorbed license (license #1260) held by BioPort Corporation.